Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ FORM 10-K __________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Registrant as Specif ...

New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology PLEASANTON, Calif., Feb. 5, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a series of new products and technology demonstrations that will be presented at the 2024 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Orlando, Florida. "The new products we have planned for 2024 ...

Yuichiro Chino/Moment via Getty Images In my previous article on 10x Genomics (NASDAQ:TXG), I debated the potential insertion of TXG in the Compounding Healthcare "Bio Boom" speculative portfolio. This deliberation was centered on the company's ability to develop cutting-edge products, services, and R&D capabilities. The article defined my game plan fixated on technical analysis and explicit conditions for entry. However, those circumstances did not appear, and I am still sitting on the sidelines, awaiting ...

10x Genomics, Inc. (NASDAQ:TXG) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Cassie Corneau - Director, Investor Relations and Strategic Finance Serge Saxonov - CEO and Co-Founder Justin McAnear - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Dan Arias - Stifel Kyle Mikson - Canaccord Genuity Dan Brennan - TD Cowen Salem Salem - Barclays Tejas Savant - Morgan Stanley John Sourbeer - UBS Mason Carrico - Stephens Michael Ryskin - Bank of Amer ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name ...

10X Genomics, Inc. (NASDAQ:TXG) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Cassie Corneau - Manager, IR and Strategic Finance Serge Saxonov - Co-Founder, CEO & Director Justin McAnear - CFO Conference Call Participants Patrick Donnelly - Citigroup Daniel Arias - Stifel, Nicolaus & Company Kyle Boucher - TD Cowen Michael Ryskin - Bank of America Merrill Lynch Tejas Savant - Morgan Stanley Matthew Larew - William Blair & Company Mason Carrico - Stephens Inc. Tianqi Hang - ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of Re ...

10x Genomics, Inc. (NASDAQ:TXG) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Cassie Corneau – Head-Investor Relations & Strategic Finance Serge Saxonov – Chief Executive Officer and Co-founder Justin McAnear – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Dan Brennan – Cowen Tejas Savant – Morgan Stanley Patrick Donnelly – Citi Matthew Sykes – Goldman Sachs Kyle Mikson – Canaccord Julia Qin – J.P. Morgan Mason Carrico – Stephens Michael Ryskin – Bank ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-39035 10x Genomics, Inc. (Exact Name of R ...

10x Genomics, Inc. (NASDAQ:TXG) Q4 2022 Earnings Conference Call February 15, 2023 4:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin McAnear - Chief Financial Officer Conference Call Participants Dan Brennan - Cowen Dan Arias - Stifel Tejas Savant - Morgan Stanley Patrick Donnelly - Citigroup Julia Qin - J.P. Morgan Kyle Mikson - Canaccord Genuity Matt Larew - William Blair Michael Ryskin - Bank of Americ ...